{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:04:35Z","timestamp":1793531075551,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008093","name":"Schulich School of Medicine and Dentistry","doi-asserted-by":"publisher","award":["Dean's Scholarship"],"award-info":[{"award-number":["Dean's Scholarship"]}],"id":[{"id":"10.13039\/501100008093","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Parkwood Institute","award":["Studentship"],"award-info":[{"award-number":["Studentship"]}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2016-05055"],"award-info":[{"award-number":["RGPIN-2016-05055"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["375104\/2017"],"award-info":[{"award-number":["375104\/2017"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010564","name":"Academic Medical Organization of Southwestern Ontario","doi-asserted-by":"publisher","award":["Opportunities Fund"],"award-info":[{"award-number":["Opportunities Fund"]}],"id":[{"id":"10.13039\/100010564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010785","name":"Canada First Research Excellence Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010785","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bucke Family Fund"},{"DOI":"10.13039\/100002734","name":"Chrysalis Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002734","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Arcangelo Rea Family Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Myo-inositol is mainly found in astroglia and its levels has been shown to be reduced in the anterior cingulate cortex (ACC) of patients with schizophrenia. We investigate the status of astroglial integrity indexed by ACC myo-inositol at the onset and over the first 6\u00a0months of treatment of first episode schizophrenia. We employed 7\u00a0T magnetic resonance spectroscopy (1H-MRS) and quantified myo-inositol spectra at the dorsal ACC in 31 participants; 21 patients with schizophrenia with median lifetime antipsychotic exposure of less than 3\u00a0days, followed up after 6\u00a0months of treatment, and 10 healthy subjects scanned twice over the same period. We studied the time by group interaction for myo-inositol after adjusting for gender and age. We report significant reduction in myo-inositol concentration in the ACC in schizophrenia at an early, untreated state of acute illness that becomes insignificant over time, after instituting early intervention. This trajectory indicates that dynamic astroglial changes are likely to operate in the early stages of schizophrenia. MRS myo-inositol may be a critical marker of amelioration of active psychosis in early stages of schizophrenia.<\/jats:p>","DOI":"10.1038\/s41598-021-01773-7","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T06:06:37Z","timestamp":1637042797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The trajectory of putative astroglial dysfunction in first episode schizophrenia: a longitudinal 7-Tesla MRS study"],"prefix":"10.1038","volume":"11","author":[{"given":"Peter","family":"Jeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mackinley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Th\u00e9berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Palaniyappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"1773_CR1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1586\/ern.09.59","volume":"9","author":"HG Bernstein","year":"2009","unstructured":"Bernstein, H. G., Steiner, J. & Bogerts, B. Glial cells in schizophrenia: Pathophysiological significance and possible consequences for therapy. Expert Rev. Neurother. 9, 1059\u20131071 (2009).","journal-title":"Expert Rev. Neurother."},{"key":"1773_CR2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1383\/psyt.2005.4.10.18","volume":"4","author":"PJ Harrison","year":"2005","unstructured":"Harrison, P. J. Neuropathology of schizophrenia. Psychiatry 4, 18\u201321 (2005).","journal-title":"Psychiatry"},{"key":"1773_CR3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.biopsych.2010.08.027","volume":"69","author":"TP Schnieder","year":"2011","unstructured":"Schnieder, T. P. & Dwork, A. J. Searching for neuropathology: Gliosis in schizophrenia. Biol. Psychiatry 69, 134\u2013139 (2011).","journal-title":"Biol. Psychiatry"},{"key":"1773_CR4","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","volume":"14","author":"M B\u00e9langer","year":"2011","unstructured":"B\u00e9langer, M., Allaman, I. & Magistretti, P. J. Brain energy metabolism: Focus on Astrocyte-neuron metabolic cooperation. Cell Metab. 14, 724\u2013738 (2011).","journal-title":"Cell Metab."},{"key":"1773_CR5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1523\/JNEUROSCI.19-02-00562.1999","volume":"19","author":"R Dringen","year":"1999","unstructured":"Dringen, R., Pfeiffer, B. & Hamprecht, B. Synthesis of the antioxidant glutathione in neurons: Supply by astrocytes of CysGly as precursor for neuronal glutathione. J. Neurosci. 19, 562\u2013569 (1999).","journal-title":"J. Neurosci."},{"key":"1773_CR6","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1042\/BST20130237","volume":"41","author":"CF Rose","year":"2013","unstructured":"Rose, C. F., Verkhratsky, A. & Parpura, V. Astrocyte glutamine synthetase: Pivotal in health and disease. Biochem. Soc. Trans. 41, 1518\u20131524 (2013).","journal-title":"Biochem. Soc. Trans."},{"key":"1773_CR7","first-page":"13","volume-title":"Glutamate Metabolism in the Brain Focusing on Astrocytes","author":"A Schousboe","year":"2014","unstructured":"Schousboe, A., Scafidi, S., Bak, L. K., Waagepetersen, H. S. & McKenna, M. C. Glutamate Metabolism in the Brain Focusing on Astrocytes 13\u201330 (Springer, 2014)."},{"key":"1773_CR8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.31887\/DCNS.2009.11.3\/mbelanger","volume":"11","author":"M B\u00e9langer","year":"2009","unstructured":"B\u00e9langer, M. & Magistretti, P. J. The role of astroglia in neuroprotection. Dialogues Clin. Neurosci. 11, 281\u2013295 (2009).","journal-title":"Dialogues Clin. Neurosci."},{"key":"1773_CR9","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn1722","volume":"6","author":"A Volterra","year":"2005","unstructured":"Volterra, A. & Meldolesi, J. Astrocytes, from brain glue to communication elements: The revolution continues. Nat. Rev. Neurosci. 6, 626\u2013640 (2005).","journal-title":"Nat. Rev. Neurosci."},{"key":"1773_CR10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.stem.2017.06.012","volume":"21","author":"MS Windrem","year":"2017","unstructured":"Windrem, M. S. et al. Human iPSC glial mouse chimeras reveal glial contributions to schizophrenia. Cell Stem Cell 21, 195\u2013208 (2017).","journal-title":"Cell Stem Cell"},{"key":"1773_CR11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.schres.2014.10.044","volume":"176","author":"M Xia","year":"2016","unstructured":"Xia, M., Abazyan, S., Jouroukhin, Y. & Pletnikov, M. Behavioral sequelae of astrocyte dysfunction: Focus on animal models of schizophrenia. Schizophr. Res. 176, 72\u201382 (2016).","journal-title":"Schizophr. Res."},{"key":"1773_CR12","doi-asserted-by":"crossref","first-page":"e89441","DOI":"10.1371\/journal.pone.0089441","volume":"9","author":"LE Duncan","year":"2014","unstructured":"Duncan, L. E. et al. Pathway analyses implicate glial cells in schizophrenia. PLoS ONE 9, e89441 (2014).","journal-title":"PLoS ONE"},{"key":"1773_CR13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0005-2760(89)90265-8","volume":"1004","author":"NT Glanville","year":"1989","unstructured":"Glanville, N. T., Byers, D. M., Cook, H. W., Spence, M. W. & Palmer, F. B. S. C. Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin. Biochim. Biophys. Acta Lipids Lipid Metab. 1004, 169\u2013179 (1989).","journal-title":"Biochim. Biophys. Acta Lipids Lipid Metab."},{"key":"1773_CR14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/nbm.1186","volume":"21","author":"E Hattingen","year":"2008","unstructured":"Hattingen, E. et al. Myo-inositol: A marker of reactive astrogliosis in glial tumors? NMR Biomed. 21, 233\u2013241 (2008).","journal-title":"NMR Biomed."},{"key":"1773_CR15","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1111\/j.1528-1167.2012.03685.x","volume":"53","author":"M Filibian","year":"2012","unstructured":"Filibian, M. et al. In vivo imaging of glia activation using 1H-magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity. Epilepsia 53, 1907\u20131916 (2012).","journal-title":"Epilepsia"},{"key":"1773_CR16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.pnpbp.2006.09.013","volume":"31","author":"M Rothermundt","year":"2007","unstructured":"Rothermundt, M. et al. Glial cell activation in a subgroup of patients with schizophrenia indicated by increased S100B serum concentrations and elevated myo-inositol. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 31, 361\u2013364 (2007).","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"1773_CR17","first-page":"202","volume":"7","author":"JL Harris","year":"2015","unstructured":"Harris, J. L., Choi, I. Y. & Brooks, W. M. Probing astrocyte metabolism in vivo: Proton magnetic resonance spectroscopy in the injured and aging brain. Front. Aging Neurosci. 7, 202 (2015).","journal-title":"Front. Aging Neurosci."},{"key":"1773_CR18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/WNL.0000000000000105","volume":"82","author":"AS Kierans","year":"2014","unstructured":"Kierans, A. S. et al. Myoinositol and glutamate complex neurometabolite abnormality after mild traumatic brain injury. Neurology 82, 521\u2013528 (2014).","journal-title":"Neurology"},{"key":"1773_CR19","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1038\/s41598-018-23155-2","volume":"8","author":"PC Geiszler","year":"2018","unstructured":"Geiszler, P. C. et al. Dynamic metabolic patterns tracking neurodegeneration and gliosis following 26S proteasome dysfunction in mouse forebrain neurons. Sci. Rep. 8, 4833 (2018).","journal-title":"Sci. Rep."},{"key":"1773_CR20","doi-asserted-by":"crossref","first-page":"19880","DOI":"10.1038\/srep19880","volume":"6","author":"MC Pardon","year":"2016","unstructured":"Pardon, M. C. et al. Magnetic Resonance Spectroscopy discriminates the response to microglial stimulation of wild type and Alzheimer\u2019s disease models. Sci. Rep. 6, 19880 (2016).","journal-title":"Sci. Rep."},{"key":"1773_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00438","author":"TK Das","year":"2018","unstructured":"Das, T. K. et al. Putative astroglial dysfunction in schizophrenia: A meta-analysis of H-MRS studies of medial prefrontal myo-inositol. Front. Psychiatry. https:\/\/doi.org\/10.3389\/fpsyt.2018.00438 (2018).","journal-title":"Front. Psychiatry."},{"key":"1773_CR22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1192\/bjp.bp.106.033670","volume":"191","author":"J Th\u00e9berge","year":"2007","unstructured":"Th\u00e9berge, J. et al. Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia. Br. J. Psychiatry 191, 325 (2007).","journal-title":"Br. J. Psychiatry"},{"key":"1773_CR23","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1038\/npp.2015.57","volume":"40","author":"J Chiappelli","year":"2015","unstructured":"Chiappelli, J. et al. Evaluation of myo-inositol as a potential biomarker for depression in schizophrenia. Neuropsychopharmacology 40, 2157\u20132164 (2015).","journal-title":"Neuropsychopharmacology"},{"key":"1773_CR24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/schbul\/sbv118","volume":"42","author":"E Plitman","year":"2016","unstructured":"Plitman, E. et al. Elevated myo-inositol, choline, and glutamate levels in the associative striatum of antipsychotic-naive patients with first-episode psychosis: A proton magnetic resonance spectroscopy study with implications for glial dysfunction. Schizophr. Bull. 42, 415\u2013424 (2016).","journal-title":"Schizophr. Bull."},{"key":"1773_CR25","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/npp.2010.252","volume":"36","author":"P Katsel","year":"2011","unstructured":"Katsel, P. et al. Astrocyte and glutamate markers in the superficial, deep, and white matter layers of the anterior cingulate gyrus in schizophrenia. Neuropsychopharmacology 36, 1171\u20131177 (2011).","journal-title":"Neuropsychopharmacology"},{"key":"1773_CR26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00406-012-0328-5","volume":"263","author":"MR Williams","year":"2013","unstructured":"Williams, M. R. et al. Astrocyte decrease in the subgenual cingulate and callosal genu in schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 263, 41\u201352 (2013).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"1773_CR27","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.3389\/fphar.2019.01612","volume":"10","author":"VV Tarasov","year":"2020","unstructured":"Tarasov, V. V. et al. Alterations of astrocytes in the context of schizophrenic dementia. Front. Pharmacol. 10, 1612 (2020).","journal-title":"Front. Pharmacol."},{"key":"1773_CR28","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1046\/j.1471-4159.2002.01041.x","volume":"82","author":"SK Fisher","year":"2002","unstructured":"Fisher, S. K., Novak, J. E. & Agranoff, B. W. Inositol and higher inositol phosphates in neural tissues: Homeostasis, metabolism and functional significance. J. Neurochem. 82, 736 (2002).","journal-title":"J. Neurochem."},{"key":"1773_CR29","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/01.ASN.0000017903.77985.CD","volume":"13","author":"A Soupart","year":"2002","unstructured":"Soupart, A., Silver, S., Schro\u00ebder, B., Sterns, R. & Decaux, G. Rapid (24-hour) reaccumulation of brain organic osmolytes (particularly myo-inositol) in azotemic rats after correction of chronic hyponatremia. J. Am. Soc. Nephrol. 13, 1433 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1773_CR30","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1681\/ASN.V1351255","volume":"13","author":"SM Silver","year":"2002","unstructured":"Silver, S. M., Schroeder, B. M. & Sterns, R. H. Brain uptake of myoinositol after exogenous administration. J. Am. Soc. Nephrol. 13, 1255 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1773_CR31","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neuint.2016.04.008","volume":"97","author":"K Raider","year":"2016","unstructured":"Raider, K. et al. A high fat diet alters metabolic and bioenergetic function in the brain: A magnetic resonance spectroscopy study. Neurochem. Int. 97, 172 (2016).","journal-title":"Neurochem. Int."},{"key":"1773_CR32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000478861","volume":"75","author":"AS Urrila","year":"2017","unstructured":"Urrila, A. S. et al. Frontal cortex myo-inositol is associated with sleep and depression in adolescents: A proton magnetic resonance spectroscopy study. Neuropsychobiology 75, 21 (2017).","journal-title":"Neuropsychobiology"},{"key":"1773_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2020.593498","author":"AL Schranz","year":"2020","unstructured":"Schranz, A. L. et al. Brain metabolite levels in sedentary women and non-contact athletes differ from contact athletes. Front. Hum. Neurosci. https:\/\/doi.org\/10.3389\/fnhum.2020.593498 (2020).","journal-title":"Front. Hum. Neurosci."},{"key":"1773_CR34","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/mrm.21709","volume":"60","author":"M Rango","year":"2008","unstructured":"Rango, M. et al. Myoinositol content in the human brain is modified by transcranial direct current stimulation in a matter of minutes: A 1H-MRS study. Magn. Reson. Med. 60, 782 (2008).","journal-title":"Magn. Reson. Med."},{"key":"1773_CR35","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1176\/ajp.156.12.1879","volume":"156","author":"W Huang","year":"1999","unstructured":"Huang, W. et al. High brain myo-inositol levels in the predementia phase of Alzheimer\u2019s disease in adults with Down\u2019s syndrome: A 1H MRS study. Am. J. Psychiatry 156, 1879\u20131886 (1999).","journal-title":"Am. J. Psychiatry"},{"key":"1773_CR36","doi-asserted-by":"crossref","first-page":"e395","DOI":"10.1212\/WNL.0000000000006852","volume":"92","author":"O Voevodskaya","year":"2019","unstructured":"Voevodskaya, O. et al. Brain myoinositol as a potential marker of amyloid-related pathology: A longitudinal study. Neurology 92, e395\u2013e405 (2019).","journal-title":"Neurology"},{"key":"1773_CR37","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3389\/fphar.2019.01172","volume":"10","author":"DR Chhetri","year":"2019","unstructured":"Chhetri, D. R. Myo-inositol and its derivatives: Their emerging role in the treatment of human diseases. Front. Pharmacol. 10, 1172 (2019).","journal-title":"Front. Pharmacol."},{"key":"1773_CR38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.mp.4001618","volume":"10","author":"AJ Harwood","year":"2005","unstructured":"Harwood, A. J. Lithium and bipolar mood disorder: The inositol-depletion hypothesis revisited. Mol. Psychiatry 10, 117\u2013126 (2005).","journal-title":"Mol. Psychiatry"},{"key":"1773_CR39","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s11481-013-9460-x","volume":"8","author":"L Chang","year":"2013","unstructured":"Chang, L., Munsaka, S. M., Kraft-Terry, S. & Ernst, T. Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain. J. Neuroimmune Pharmacol. 8, 576\u2013593 (2013).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"1773_CR40","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.neuroimage.2010.10.017","volume":"54","author":"M Haris","year":"2011","unstructured":"Haris, M., Cai, K., Singh, A., Hariharan, H. & Reddy, R. In vivo mapping of brain myo-inositol. Neuroimage 54, 2079\u20132085 (2011).","journal-title":"Neuroimage"},{"key":"1773_CR41","first-page":"125","volume":"5","author":"EA Woodcock","year":"2019","unstructured":"Woodcock, E. A., Hillmer, A. T., Mason, G. F. & Cosgrove, K. P. Imaging biomarkers of the neuroimmune system among substance use disorders: A systematic review. Mol. Neuropsychiatry 5, 125\u2013146 (2019).","journal-title":"Mol. Neuropsychiatry"},{"key":"1773_CR42","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.biopsych.2007.08.018","volume":"63","author":"GT Konopaske","year":"2008","unstructured":"Konopaske, G. T. et al. Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol. Psychiatry 63, 759\u2013765 (2008).","journal-title":"Biol. Psychiatry"},{"key":"1773_CR43","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.biopsych.2013.09.012","volume":"75","author":"AC Vernon","year":"2014","unstructured":"Vernon, A. C. et al. Reduced cortical volume and elevated astrocyte density in rats chronically treated with antipsychotic drugs\u2014Linking magnetic resonance imaging findings to cellular pathology. Biol. Psychiatry 75, 982\u2013990 (2014).","journal-title":"Biol. Psychiatry"},{"key":"1773_CR44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-3223(99)00113-4","volume":"46","author":"LD Selemon","year":"1999","unstructured":"Selemon, L. D., Lidow, M. S. & Goldman-Rakic, P. S. Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure. Biol. Psychiatry 46, 161\u2013172 (1999).","journal-title":"Biol. Psychiatry"},{"key":"1773_CR45","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.schres.2020.03.069","volume":"222","author":"M Kubota","year":"2020","unstructured":"Kubota, M., Moriguchi, S., Takahata, K., Nakajima, S. & Horita, N. Treatment effects on neurometabolite levels in schizophrenia: A systematic review and meta-analysis of proton magnetic resonance spectroscopy studies. Schizophr. Res. 222, 122\u2013132 (2020).","journal-title":"Schizophr. Res."},{"key":"1773_CR46","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S2215-0366(19)30302-5","volume":"7","author":"AG Dietz","year":"2020","unstructured":"Dietz, A. G., Goldman, S. A. & Nedergaard, M. Glial cells in schizophrenia: A unified hypothesis. The Lancet Psychiatry 7, 272\u2013281 (2020).","journal-title":"The Lancet Psychiatry"},{"key":"1773_CR47","doi-asserted-by":"crossref","first-page":"100034","DOI":"10.1016\/j.bbih.2019.100034","volume":"2","author":"PGC Almeida","year":"2020","unstructured":"Almeida, P. G. C., Nani, J. V., Oses, J. P., Brietzke, E. & Hayashi, M. A. F. Neuroinflammation and glial cell activation in mental disorders. Brain Behav. Immun. Health 2, 100034 (2020).","journal-title":"Brain Behav. Immun. Health"},{"key":"1773_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/schizbullopen\/sgaa072","volume":"2","author":"P Jeon","year":"2021","unstructured":"Jeon, P. et al. Progressive changes in glutamate concentration in early stages of schizophrenia\u2014A longitudinal 7-Tesla MRS study. Schizophr. Bull. Open 2, 1\u20139 (2021).","journal-title":"Schizophr. Bull. Open"},{"key":"1773_CR49","volume-title":"Structured Clinical Interview for DSM-5 Research Version","author":"MB First","year":"2015","unstructured":"First, M. B., Williams, J. B. W., Karg, R. S. & Spitzer, R. L. Structured Clinical Interview for DSM-5 Research Version (American Psychiatric Association, 2015)."},{"key":"1773_CR50","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archpsyc.1982.04290080001001","volume":"39","author":"JF Leckman","year":"1982","unstructured":"Leckman, J. F., Sholomskas, D., Thompson, D., Belanger, A. & Weissman, M. M. Best estimate of lifetime psychiatric diagnosis: A methodological study. Arch. Gen. Psychiatry 39, 879\u2013883 (1982).","journal-title":"Arch. Gen. Psychiatry"},{"key":"1773_CR51","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1177\/0706743717719900","volume":"62","author":"D Addington","year":"2017","unstructured":"Addington, D., Anderson, E., Kelly, M., Lesage, A. & Summerville, C. Canadian practice guidelines for comprehensive community treatment for schizophrenia and schizophrenia spectrum disorders. Can. J. Psychiatry 62, 662\u2013672 (2017).","journal-title":"Can. J. Psychiatry"},{"key":"1773_CR52","doi-asserted-by":"crossref","first-page":"110297","DOI":"10.1016\/j.pnpbp.2021.110297","volume":"110","author":"MTM Park","year":"2021","unstructured":"Park, M. T. M. et al. Hippocampal neuroanatomy in first episode psychosis: A putative role for glutamate and serotonin receptors. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 110, 110297 (2021).","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"1773_CR53","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3390\/brainsci11070941","volume":"11","author":"P Jeon","year":"2021","unstructured":"Jeon, P. et al. Glutathione as a molecular marker of functional impairment in patients with at-risk mental state: 7-Tesla 1H-MRS study. Brain Sci. 11, 941 (2021).","journal-title":"Brain Sci."},{"key":"1773_CR54","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/acps.12849","volume":"137","author":"CH Lin","year":"2018","unstructured":"Lin, C. H. et al. Early improvement in PANSS-30, PANSS-8, and PANSS-6 scores predicts ultimate response and remission during acute treatment of schizophrenia. Acta Psychiatr. Scand. 137, 98\u2013108 (2018).","journal-title":"Acta Psychiatr. Scand."},{"key":"1773_CR55","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","volume":"162","author":"NC Andreasen","year":"2005","unstructured":"Andreasen, N. C. et al. Remission in schizophrenia: Proposed criteria and rationale for consensus. Am. J. Psychiatry 162, 441 (2005).","journal-title":"Am. J. Psychiatry"},{"key":"1773_CR56","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1600-0447.2000.tb10933.x","volume":"101","author":"PL Morosini","year":"2000","unstructured":"Morosini, P. L., Magliano, L., Brambilla, L., Ugolini, S. & Pioli, R. Development, reliability and acceptability of a new version of the DSM-IV social occupational functioning assessment scale (SOFAS) to assess routine social functioning. Acta Psychiatr. Scand. 101, 323 (2000).","journal-title":"Acta Psychiatr. Scand."},{"key":"1773_CR57","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.schres.2005.04.018","volume":"80","author":"SP Singh","year":"2005","unstructured":"Singh, S. P. et al. Determining the chronology and components of psychosis onset: The Nottingham Onset Schedule (NOS). Schizophr. Res. 80, 117\u2013130 (2005).","journal-title":"Schizophr. Res."},{"key":"1773_CR58","unstructured":"IBM Corp. IBM SPSS Statistics for Windows, Version 26.0. 2019 (2019)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01773-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01773-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01773-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T12:21:14Z","timestamp":1670070074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01773-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1773"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-01773-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-276635\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,16]]},"assertion":[{"value":"26 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LP reports personal fees from Otsuka Canada, SPMM Course Limited, UK, Canadian Psychiatric Association; book royalties from Oxford University Press; investigator-initiated educational grants from Janssen Canada, Sunovion and Otsuka Canada outside the submitted work. All other authors report no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22333"}}